Published in Pediatr Surg Int on September 22, 2017
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr (2003) 3.38
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med (2013) 3.35
Biliary atresia. Lancet (2009) 3.28
Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res (2004) 2.38
Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology (2007) 1.76
Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics (2011) 1.75
Serial circulating markers of inflammation in biliary atresia--evolution of the post-operative inflammatory process. Hepatology (2007) 1.61
Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg (2001) 1.55
Microtubules in transcellular movement of procollagen. Nat New Biol (1972) 1.53
Etiopathogenesis of biliary atresia. Semin Liver Dis (2001) 1.52
The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr (2006) 1.42
Biliary atresia splenic malformation syndrome: an etiologic and prognostic subgroup. Surgery (1993) 1.41
Cystic biliary atresia: an etiologic and prognostic subgroup. J Pediatr Surg (2008) 1.40
Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol (2008) 1.23
Corticosteroid therapy in biliary atresia. J Pediatr Surg (1985) 1.16
High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg (2003) 1.12
The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg (1997) 1.11
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology (1996) 1.06
Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome. Pediatr Surg Int (2001) 0.99
Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA (2014) 0.98
Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy. J Pediatr Surg (2003) 0.97
Cholangitis after hepatic portoenterostomy for biliary atresia: a multivariate analysis of risk factors. J Pediatr (2003) 0.93
Biliary atresia in the Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr (2011) 0.93
Cytomegalovirus-associated biliary atresia: An aetiological and prognostic subgroup. J Pediatr Surg (2015) 0.93
Current concept about postoperative cholangitis in biliary atresia. World J Pediatr (2008) 0.92
Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia. Hepatology (2014) 0.91
Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg (2007) 0.87
Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients: results from a single institution. J Pediatr Surg (2013) 0.87
Early cytomegalovirus infection and the long-term outcome of biliary atresia. Acta Paediatr (2009) 0.84
Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol (2013) 0.84
Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther (2006) 0.84
Late-presenting cholangitis and Roux loop obstruction after Kasai portoenterostomy for biliary atresia. J Pediatr Surg (2006) 0.83
Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics (2008) 0.83
Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia. Pediatr Surg Int (2013) 0.83
Relationship between prognosis of biliary atresia and infection of cytomegalovirus. World J Pediatr (2008) 0.82
Perioperative factors affecting the outcome following repair of biliary atresia. Pediatrics (1989) 0.82
Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis? Eur J Gastroenterol Hepatol (1999) 0.80
Prednisolone increases enterohepatic cycling of bile acids by induction of Asbt and promotes reverse cholesterol transport. J Hepatol (2014) 0.79
Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome. J Pediatr Surg (2015) 0.79
Effects of the herbal medicine Inchinko-to on liver function in postoperative patients with biliary atresia--a pilot study. J Pediatr Surg (2003) 0.79
Improved outcome of biliary atresia with postoperative high-dose steroid. Gastroenterol Res Pract (2013) 0.79
Effects of ursodeoxycholic acid treatment on essential fatty acid deficiency in patients with biliary atresia. J Pediatr Surg (1994) 0.79
Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatr Surg Int (2015) 0.78
Biliary atresia: current management and outcome. Tohoku J Exp Med (1997) 0.78
Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia. J Pediatr Surg (2008) 0.78
Hepatic Prominin-1 expression is associated with biliary fibrosis. Surgery (2017) 0.77
Detection of hepatotropic viruses has no impact on the prognosis after Kasai procedure. J Pediatr Surg (2012) 0.77
Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol (1993) 0.77
Effects of postoperative cholestyramine and phenobarbital administration on bile flow restoration in infants with extrahepatic biliary atresia. J Pediatr Surg (1986) 0.77
Biliary atresia and cytomegalovirus and response to valganciclovir. Indian Pediatr (2012) 0.77
Cystic Biliary Atresia and Choledochal Cysts are Distinct Histopathologic Entities. Am J Surg Pathol (2017) 0.76
Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis. F1000Res (2016) 0.76
Prophylactic Antibiotics for Prevention of Cholangitis in Patients With Biliary Atresia Status Post-Kasai Portoenterostomy: A Systematic Review. Clin Pediatr (Phila) (2015) 0.76
Inchin-ko-to prevents medium-term liver fibrosis in postoperative biliary atresia patients. Pediatr Surg Int (2007) 0.76
Glucocorticoid treatment alters systemic bile acid homeostasis by regulating the biosynthesis and transport of bile salts. Dig Liver Dis (2016) 0.76
Postoperative steroid therapy for biliary atresia: Systematic review and meta-analysis. J Pediatr Surg (2015) 0.76
High-dose IgG therapy mitigates bile duct-targeted inflammation and obstruction in a mouse model of biliary atresia. Pediatr Res (2014) 0.76
Suppression of Rat Stellate Cell Activation and Liver Fibrosis by a Japanese Herbal Medicine, Inchinko-to (TJ135). Comp Hepatol (2004) 0.76
Prematurity and biliary atresia: a 30-year observational study. Pediatr Surg Int (2017) 0.75
Growth in children with choledochal malformations: effect of the Roux loop. Pediatr Surg Int (2015) 0.75